Protagonist Therapeutics, Inc (PTGX)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
38
$5.03B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $1.26B |
| Vanguard Portfolio Management | Aug 13, 2026 | $444.88M |
| WELLINGTON MANAGEMENT GROUP LLP | Aug 14, 2026 | $418.83M |
| UBS Group AG | Aug 13, 2026 | $416.68M |
| STATE STREET CORP | Aug 7, 2026 | $407.16M |
PTGX's filings are public. The insight is one click away.
Scrutar's AI reads every PTGX filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze PTGX filingsNo credit cardAI reports included on the free plan
Never miss a PTGX filing.
Get an email when PTGX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 30, 2026Source: SEC EDGAR.